Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: DaveAu who wrote (7582)	8/3/2001 8:27:50 PM
From: DaveAu	Respond to of 14101

Anyone still think labelling is a trivial task ? We now know each application is expected to be .5 to 1 ml per joint, 4 times a day. So one 60 ml bottle should last 30 days for a typical patient treating one joint. I'll bet most people splash on more than that in an application but probably don't do it 4 times. Also note that you're not supposed to use it more than 12 weeks after opening. Dave

To: DaveAu who wrote (7582)	8/3/2001 9:12:09 PM
From: jef saunders	Respond to of 14101

> ... and gastrointestinal bleeding, sometimes severe and occasionally (rarely) fatal i remember some statistic saying that nsaids (or was it just vioxx and celebrex alone?) killed some 20,000 people last year. but "rarely" fatal would negate that ?